This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Andrew Bradbury, MD, PhD
Chief Scientific Officer at Specifica

Profile

Andrew Bradbury is Chief Scientific Officer of Specifica, a company he founded in 2016, after retiring as Group Leader at LANL. He trained in medicine at the Universities of Oxford and London and received his PhD from the University of Cambridge at the MRC Laboratory of Molecular Biology, under the guidance of Cesar Milstein. He has worked in antibody engineering for over thirty years. Specifica's mission is to provide companies developing therapeutic antibodies with the world’s best antibody selection platform.

Agenda Sessions

  • Workshop Co-Moderators' Remarks

    1:00pm
  • Chairman’s Remarks

    2:25pm
  • Drug-like Antibodies Straight from Selections: Enhanced Affinity and Developability from Specifica’s Generation 3 Platform

    2:30pm